Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NDRA - ENDRA Life Sciences Inc.

IEX Last Trade
6.55
0.230   3.511%

Share volume: 746
Last Updated: Fri 27 Dec 2024 08:00:22 PM CET
Surgical and Medical Instrument Manufacturing : -0.06%

PREVIOUS CLOSE
CHG
CHG%
$6.32
0.23
3.64%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
23%
Profitability 25%
Dept financing 23%
Liquidity 47%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.07%
1 Month
-8.43%
3 Months
2,569.88%
6 Months
5,440.00%
1 Year
179.80%
2 Year
20.17%
Key data
Stock price
$6.55
P/E Ratio 
0.00
DAY RANGE
$5.77 - $6.40
EPS 
$0.00
52 WEEK RANGE
$0.04 - $8.80
52 WEEK CHANGE
$161.32
MARKET CAP 
27.723 M
YIELD 
N/A
SHARES OUTSTANDING 
72.440 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$47,788
AVERAGE 30 VOLUME 
$60,045
Company detail
CEO: Francois Michelon
Region: US
Website: endrainc.com
Employees: 20
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology. Technology transmits sound waves, which bounce off tissues, organs, and blood in the body. Thermoablative surgery, vascular imaging, and tissue perfusion technologies also offer diagnostic imaging technologies.

Recent news